I Agree

We have updated our Privacy and Cookie Policy. By clicking "I Agree" below, you acknowledge that you accept our Privacy and Cookie Policy and Terms of Use.

PLEASE TELL US A LITTLE ABOUT YOURSELF SO THAT WE CAN DISPLAY THE MOST
APPROPRIATE CONTENT TO YOU:

This site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about cookies used on Trustnet and how you can manage them, see our Privacy and Cookie Policy.

By clicking "I Agree" below, you acknowledge that you accept our Privacy Policy and Terms of Use.

For more information Click here

Login

Register

It's look like you're leaving us

What would you like us to do with the funds you've selected

Show me all my options Forget them Save them
Customise this table
You are here: ARIX BIOSCIENCE ORD 0.001P ARIX Announcements

ARIX BIOSCIENCE ORD 0.001P (ARIX) Announcements

Date Time Source Announcement
10 Jul 2020 7:53 am
PRN
Atox Bio plans NDA submission for Q3 2020
08 Jul 2020 1:27 pm
PRN
VelosBio completes $137 million Series B financing
01 Jul 2020 7:00 am
PRN
Director/PDMR Shareholding, Issue of Ordinary S...
12 Jun 2020 2:24 pm
PRN
Aura presents updated AU-011 clinical data at A...
  1:34 pm
PRN
Imara presents positive interim Phase 2a data a...
  9:13 am
PRN
Autolus AUTO1 and AUTO3 data at EHA
08 Jun 2020 7:08 am
PRN
Arix announces strategic and operational update
04 Jun 2020 5:42 pm
PRN
Results of Annual General Meeting
01 Jun 2020 2:57 pm
PRN
Iterum announces topline Phase 3 data in compli...
29 May 2020 1:38 pm
PRN
Harpoon presents interim Phase 1 data for HPN424
  1:06 pm
PRN
Autolus presents additional AUTO3 data in DLBCL
27 May 2020 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
20 May 2020 7:00 am
PRN
Amplyx closes $53 million Series C extension
19 May 2020 9:35 am
EQS
Arix Bioscience (ARIX): 1Q'20 portfolio update
12 May 2020 7:00 am
PRN
Notice of Annual General Meeting
28 Apr 2020 9:23 am
PRN
Pharmaxis announces new data in myelofibrosis
27 Apr 2020 1:12 pm
PRN
Harpoon doses first patient in multiple myeloma...
23 Apr 2020 7:30 am
EQS
Arix Bioscience (ARIX): Resetting the stage
17 Apr 2020 2:59 pm
PRN
Director/PDMR Shareholding
16 Apr 2020 1:08 pm
PRN
Autolus announces FDA acceptance of IND applica...
06 Apr 2020 7:00 am
PRN
Changes to Board of Directors and executive lea...
19 Mar 2020 10:30 am
EQS
Arix Bioscience (ARIX): Fiscal 2019 - moving wi...
16 Mar 2020 7:00 am
PRN
Director/PDMR Shareholding
12 Mar 2020 7:11 am
PRN
Imara prices Nasdaq IPO
10 Mar 2020 7:00 am
PRN
Annual Results for the year ended 31 December 2019
09 Mar 2020 12:00 pm
PRN
Dr Roberto Iacone appointed as EiR
03 Mar 2020 12:18 pm
PRN
Update on Imara proposed IPO in the United States
  7:30 am
EQS
Q&A with Q&A with Dr Dorothea Hill on A...
27 Feb 2020 12:00 pm
PRN
Notice of Results
24 Feb 2020 1:26 pm
PRN
Aura announces updated Phase 1b/2 clinical data
19 Feb 2020 7:30 am
EQS
Arix Bioscience (ARIX) - Initiation of coverage...
17 Feb 2020 7:00 am
PRN
Imara files for proposed IPO in the United States
30 Jan 2020 12:08 pm
PRN
Autolus presents encouraging additional AUTO3 data
27 Jan 2020 7:00 am
PRN
Arix co-founds Quench Bio with Series A financing
23 Jan 2020 7:00 am
PRN
Autolus announces pricing of public offering
17 Jan 2020 1:15 pm
PRN
Iterum announces $52 million private placement
18 Dec 2019 10:00 am
PRN
Pharmaxis business update
17 Dec 2019 10:57 am
PRN
Board changes
11 Dec 2019 7:05 am
PRN
Iterum announces topline Phase 3 data
09 Dec 2019 7:01 am
PRN
Autolus announces new AUTO3 data at ASH
  7:00 am
PRN
Autolus announces key new data at ASH
22 Nov 2019 9:57 am
PRN
Holding(s) in Company
21 Nov 2019 12:06 pm
PRN
Harpoon and AbbVie announce licensing and optio...
07 Nov 2019 12:22 pm
PRN
Autolus reports Q3 2019 financial results
  7:22 am
PRN
Change of Broker
06 Nov 2019 2:31 pm
PRN
Autolus to present new data at the ASH Annual M...
  7:02 am
PRN
Artios expands DDR pipeline with new asset
17 Oct 2019 1:40 pm
PRN
Holding(s) in Company
16 Oct 2019 8:00 am
PRN
Aura reports updated Phase 1b/2 clinical data f...
15 Oct 2019 3:20 pm
PRN
]Holding(s) in Company
03 Oct 2019 7:06 am
PRN
2019 Capital Markets Day
02 Oct 2019 7:00 am
PRN
Management change
30 Sep 2019 7:00 am
PRN
Arix co-leads EUR 20m Series A financing in STipe
17 Sep 2019 7:47 am
PRN
Amplyx unveils expanded pipeline and Phase 2 data
28 Aug 2019 7:00 am
PRN
Interim results for the six months ended 30 Jun...
20 Aug 2019 7:25 am
PRN
Notice of Results
08 Aug 2019 1:03 pm
PRN
Autolus reports Q2 2019 financial results
01 Aug 2019 7:00 am
PRN
Total Voting Rights
08 Jul 2019 3:34 pm
PRN
Holding(s) in Company
Data provided by FE fundinfo. Care has been taken to ensure that the information is correct, but FE fundinfo neither warrants, represents nor guarantees the contents of information, nor does it accept any responsibility for errors, inaccuracies, omissions or any inconsistencies herein. Past performance does not predict future performance, it should not be the main or sole reason for making an investment decision. The value of investments and any income from them can fall as well as rise.

You are currently using an old browser which will not be supported by Trustnet after 31/07/2016. To ensure you benefit from all features on the site, please update your browser.   Close